Elevated levels of S100B have been observed in neurodegenerative diseases and brain injuries, such as Alzheimer’s Disease, Parkinson’s Disease, Down syndrome, and stroke, where it may act as a damage-associated molecular pattern (DAMP) protein [26, 27]. Here, S100B is linked to stroke disorder.